Polyphor Company

Clinical stage, Swiss biopharmaceutical company leading the research and development of a new mechanism of action in solid tumors, CXCR4 inhibition, for combination treatment in oncology

Investors

Industry: PharmTech
Headquarters: Basel
Founded Date: 1996
Visit Website
Register and Claim Ownership